Samir Rashmikant Patel's Net Worth

$337 Million

Estimate Recalculated Sep 18, 2024 03:41PM EST

Who is Samir Rashmikant Patel?

Samir Rashmikant Patel has an estimated net worth of $337 Million. This is based on reported shares across multiple companies, which include CytoDyn Inc., and Akari Therapeutics Plc.

SEC CIK

Samir Rashmikant Patel's CIK is 0001702447

Past Insider Trading and Trends

2021 was Samir Rashmikant Patel's most active year for acquiring shares with 7 total transactions. Samir Rashmikant Patel's most active month to acquire stocks was the month of October. 2021 was Samir Rashmikant Patel's most active year for disposing of shares, totalling 6 transactions. Samir Rashmikant Patel's most active month to dispose stocks was the month of October. 2020 saw Samir Rashmikant Patel paying a total of $27,740.25 for 237,329 shares, this is the most they've acquired in one year. In 2021 Samir Rashmikant Patel cashed out on 924,658 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CytoDyn Inc. (CYDY) Snapshot price: $0.1585

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
—
0
—
—
0
Nov 24
Form 4
—
0
—
—
0
Nov 24
Form 4
—
0
—
—
0
Oct 18
Form 4
—
0
—
—
0
Jun 25
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
Apr 17
Form 3
—
0
—
—
0
No matching records found

Akari Therapeutics Plc (AKTX) Snapshot price: $3.69

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
91.4M
—
—
91.4M
Jun 30
Form 4
+63.60%
1.33B
—
$1,193,632.20
3.41B
May 31
Form 3
—
0
—
—
0
No matching records found